Panel Discussion & Live Audience Q&A: Unlocking the Next Generation of Biomarker Discovery to Advance Clinical Assets: A Case Study with Pionyr Immunotherapeutics

Time: 6:35 pm
day: From Discovery to Clinic: New Opportunities for Biomarker Success - Agenda


• Hear from Pionyr Immunotherapeutics on the challenges faced when trying to find a good quality reagent in the early development stages and how to overcome them
• From pharma’s perspective, discover the importance of a strong partnership to enhance your  development journey and move up through the clinical development chain
• Discover how Abcam can help create a frictionless experience by providing you with the infrastructure and network to improve and speed up the development of the next generation of immunotherapies